FDA Approves Drug Combo for Metastatic Non-Small Cell Lung Cancer

TUESDAY, Nov. 15, 2022 -- The U.S. Food and Drug Administration approved the combination of tremelimumab (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer with no...